Transcription of Q 7 Good Manufacturing Practice for Active …
{{id}} {{{paragraph}}}
Example: bachelor of science
Q 7 Good Manufacturing Practice for Active …
European Medicines Agency 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 85 75 Fax (44-20) 75 23 70 40 E-mail: EMEA 2006 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged November 2000 CPMP/ICH/4106/00 ICH Topic Q 7 good Manufacturing Practice for Active Pharmaceutical Ingredients Step 5 NOTE FOR GUIDANCE ON good Manufacturing Practice FOR Active PHARMACEUTICAL INGREDIENTS (CPMP/ICH/4106/00) TRANSMISSION TO CPMP July 2000 RELEASE FOR CONSULTATION July 2000 DEADLINE FOR COMMENTS September 2000 SUBMISSION TO CPMP FOR INFORMATION November 2000 RELEASE FOR INFORMATION November 2000 Note: Date for coming into operation for this guideline will be released by the European Commission, DG Enterprise, Unit for Pharmaceuticals ( ). EMEA 2006 2 good Manufacturing Practice FOR Active PHARMACEUTICAL INGREDIENTS TABLE OF CONTENTS Section Title 1 Introduction Objective Regulatory Applicability Scope 2 Quality Management Principles Responsibilities of the Quality Unit(s) Responsibility for Production Activities Internal Audits (Self-Inspectio)
© EMEA 2006 2 GOOD MANUFACTURING PRACTICE FOR ACTIVE PHARMACEUTICAL INGREDIENTS TABLE OF CONTENTS Section Title 1 …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: